PA8797801A1 - USE OF 2-SULPHONYLAMINOBENZOIC ACID N-PHENYLAMIDES REPLACED WITH SULFONYL IN PAIN TREATMENT - Google Patents

USE OF 2-SULPHONYLAMINOBENZOIC ACID N-PHENYLAMIDES REPLACED WITH SULFONYL IN PAIN TREATMENT

Info

Publication number
PA8797801A1
PA8797801A1 PA20088797801A PA8797801A PA8797801A1 PA 8797801 A1 PA8797801 A1 PA 8797801A1 PA 20088797801 A PA20088797801 A PA 20088797801A PA 8797801 A PA8797801 A PA 8797801A PA 8797801 A1 PA8797801 A1 PA 8797801A1
Authority
PA
Panama
Prior art keywords
sulphonylaminobenzoic
phenylamides
sulfonyl
acid
replaced
Prior art date
Application number
PA20088797801A
Other languages
Spanish (es)
Inventor
Guehring Hans
Rudolphi Karl
Michaelis Martin
Original Assignee
Sanofi Aventis
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Aventis filed Critical Sanofi Aventis
Publication of PA8797801A1 publication Critical patent/PA8797801A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/18—Sulfonamides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/63—Compounds containing para-N-benzenesulfonyl-N-groups, e.g. sulfanilamide, p-nitrobenzenesulfonyl hydrazide
    • A61K31/635—Compounds containing para-N-benzenesulfonyl-N-groups, e.g. sulfanilamide, p-nitrobenzenesulfonyl hydrazide having a heterocyclic ring, e.g. sulfadiazine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyridine Compounds (AREA)

Abstract

USO DE N-FENILAMIDAS DE ÀCIDO 2 -SULFONILAMINOBENZOICO SUSTITUIDAS CON SULFONILO EN EL TRATAMIENTO DEL DOLOR. LA PRESENTE INVENCIÒN SE REFIERE AL USO DE N-FENILAMIDAS DE ÀCIDO 2- SULFONILAMINOBENZOICO SUSTITUIDAS CON SULFONILO DE FÒRMULA I, EN LA QUE A Y R1 A R5 TIENEN LOS SIGNIFICADOS INDICADOS EN LAS REIVINDICACIONES, PARA TRATAR EL DOLOR Y PARA FABRICAR UN MEDICAMENTO PARA EL TRATAMIENTO DEL DOLOR.USE OF N-PHENYLAMIDES OF ACID 2 -SULPHONYLAMINOBENZOIC SUBSTITUTED WITH SULFONYL IN PAIN TREATMENT. THIS INVENTION REFERS TO THE USE OF N-PHENYLAMIDES OF ACID 2- SULPHONYLAMINOBENZOIC SUBSTITUTED WITH SULFONYL OF FÒRMULA I, IN WHICH A AND R1 TO R5 HAVE THE MEANINGS INDICATED IN THE CLAIMS, FOR THE TREATMENT OF TREATMENT AND PROCESSING FROM PAIN.

PA20088797801A 2007-10-05 2008-10-03 USE OF 2-SULPHONYLAMINOBENZOIC ACID N-PHENYLAMIDES REPLACED WITH SULFONYL IN PAIN TREATMENT PA8797801A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP07019521 2007-10-05
EP08013725 2008-07-31

Publications (1)

Publication Number Publication Date
PA8797801A1 true PA8797801A1 (en) 2009-06-23

Family

ID=40042693

Family Applications (1)

Application Number Title Priority Date Filing Date
PA20088797801A PA8797801A1 (en) 2007-10-05 2008-10-03 USE OF 2-SULPHONYLAMINOBENZOIC ACID N-PHENYLAMIDES REPLACED WITH SULFONYL IN PAIN TREATMENT

Country Status (17)

Country Link
US (1) US8518998B2 (en)
EP (1) EP2207541B1 (en)
JP (1) JP5487107B2 (en)
KR (1) KR20100063109A (en)
CN (1) CN101815514B (en)
AR (1) AR071049A1 (en)
BR (1) BRPI0817483A2 (en)
CA (1) CA2706241C (en)
CL (1) CL2008002942A1 (en)
ES (1) ES2527948T3 (en)
HK (1) HK1143756A1 (en)
IL (1) IL204668A (en)
MX (1) MX2010003071A (en)
PA (1) PA8797801A1 (en)
PE (1) PE20090961A1 (en)
TW (1) TW200932247A (en)
WO (1) WO2009043495A1 (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5715713B2 (en) 2011-03-10 2015-05-13 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング Soluble guanylate cyclase activator
EP2766360B1 (en) 2011-08-12 2017-07-12 Boehringer Ingelheim International GmbH Soluble guanylate cyclase activators
PL2892891T3 (en) * 2012-09-07 2020-01-31 Boehringer Ingelheim International Gmbh Alkoxy pyrazoles as soluble guanylate cyclase activators
CA2904160C (en) * 2013-03-15 2022-08-23 The California Institute For Biomedical Research Phenyl sulfonamide derivatives and use thereof in the treatment of arthritis
SG10201806565SA (en) 2014-07-22 2018-08-30 Boehringer Ingelheim Int Heterocyclic carboxylic acids as activators of soluble guanylate cyclase
EP2990403A1 (en) 2014-08-29 2016-03-02 Novartis Tiergesundheit AG Anthranilamides, sulfonamides and nitro analogues derived therefrom as anthelmintics
CN104892466B (en) * 2015-04-30 2018-05-29 中国科学技术大学 A kind of synthesis of aniline sulphonyl class compound and its application as inhibition of HIV inhibitor

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US684287A (en) * 1900-03-15 1901-10-08 Millhiser Mfg Company Bag-stringing machine.
CZ302691B6 (en) * 1998-07-08 2011-09-07 Sanofi - Aventis Deutschland GmbH N-arylamide compound, process for its preparation, pharmaceutical composition containing thereof, the compound for use as activator and for use in therapy or prophylaxis
GB9824579D0 (en) 1998-11-10 1999-01-06 Novartis Ag Organic compounds
DE19943634A1 (en) * 1999-09-13 2001-04-12 Bayer Ag Novel dicarboxylic acid derivatives with pharmaceutical properties
DE10122894A1 (en) * 2001-05-11 2002-11-14 Bayer Ag New pyrazolo(3,4-b)pyridin-3-yl)-5-pyrimidinyl sulfonates, are soluble guanyl cyclase stimulants useful e.g. for treating cardiovascular, thromboembolic or central nervous system diseases
DOP2003000556A (en) * 2002-01-23 2003-10-31 Warner Lambert Co ESTERES HYDROXAMATE ACID N- (4-PHENYL-REPLACED) -ANTRANILICO.
US20040192680A1 (en) * 2002-12-20 2004-09-30 Anderson Steven N. Novel amides that activate soluble guanylate cyclase
DE102005031575A1 (en) * 2005-07-06 2007-01-11 Bayer Healthcare Ag Use of soluble guanylate cyclase activators to promote wound healing

Also Published As

Publication number Publication date
MX2010003071A (en) 2010-04-01
CA2706241C (en) 2015-12-22
CA2706241A1 (en) 2009-04-09
EP2207541A1 (en) 2010-07-21
CL2008002942A1 (en) 2009-06-05
TW200932247A (en) 2009-08-01
US8518998B2 (en) 2013-08-27
AU2008306207A1 (en) 2009-04-09
PE20090961A1 (en) 2009-08-10
KR20100063109A (en) 2010-06-10
ES2527948T3 (en) 2015-02-02
WO2009043495A1 (en) 2009-04-09
EP2207541B1 (en) 2014-10-29
CN101815514B (en) 2012-05-09
JP2010540581A (en) 2010-12-24
AR071049A1 (en) 2010-05-26
IL204668A0 (en) 2010-11-30
CN101815514A (en) 2010-08-25
IL204668A (en) 2013-10-31
BRPI0817483A2 (en) 2016-07-26
HK1143756A1 (en) 2011-01-14
JP5487107B2 (en) 2014-05-07
US20110021505A1 (en) 2011-01-27

Similar Documents

Publication Publication Date Title
CO2017004525A2 (en) Ror-gamma inhibitory dihydropyrrolopyridines
UY35427A (en) COMPOUNDS AND THEIR USES IN THE MODULATION OF HEMOGLOBIN
UY35425A (en) COMPOUNDS AND THEIR USES IN THE MODULATION OF HEMOGLOBIN
CL2013000304A1 (en) Compounds derived from prostaglandin e2 inhibitor 2-arylamino-benzimidazoles (mpges-1); pharmaceutical composition that includes them; intermediary compounds; use in the treatment of inflammatory diseases and / or associated conditions, in particular pain.
UY32926A (en) COMPOUNDS AS ANTAGONISTS OF LISOPHOSPHATIDIC ACID RECEPTORS
UY35426A (en) COMPOUNDS AND THEIR USES IN THE MODULATION OF HEMOGLOBIN
CL2013001338A1 (en) Compounds derived from substituted benzothiene-pyridines, hiv replication inhibitors; pharmaceutical composition that includes them; pharmaceutical combination; pharmaceutical kit; and its use for the treatment of hiv.
EA201270619A1 (en) USE OF BETANEHOL FOR THE TREATMENT OF XEROSTOMY
CL2013002517A1 (en) Compounds derived from 5-fluoro-2'-deoxyuridine phosphoramidate; preparation procedure; pharmaceutical composition that includes them; its use in the treatment or prophylaxis of cancer.
GT201200165A (en) TRIAZOLOPIRIDINS
GT201400111A (en) SUBSTITUTED TRIAZOLOPIRIDINS
DOP2013000036A (en) CYCLLOBUTAN DERIVATIVES AS JAK INHIBITORS
UY34201A (en) AZAINDOL COMPOUNDS AND METHODS FOR HIV TREATMENT.
CL2010001637A1 (en) Compounds derived from isoindolones; pharmaceutical composition comprising them; and its use as mek kinase inhibitors to treat hyperproliferative and / or inflammatory diseases such as cancer, rheumatoid arthritis among others.
CO6640285A2 (en) 5-alkynyl pyrimidines
ECSP10010548A (en) COMPOSITIONS AND METHODS OF PREPARATION AND USE OF THE SAME
UY34467A (en) PROCEDURE FOR THE PREPARATION OF REPLACED 5-FLUORO-1H-PIRAZOLOPIRIDINAS
ECSP13012573A (en) 6-amino-nicotinamides substituted as modulators of KCNQ2 / 3
PA8797801A1 (en) USE OF 2-SULPHONYLAMINOBENZOIC ACID N-PHENYLAMIDES REPLACED WITH SULFONYL IN PAIN TREATMENT
UY34797A (en) BICYCLICALLY REPLACED URACILES AND USE OF THE SAME
DOP2012000312A (en) SUBSTITUTED TRIAZOLOPIRIDINS
CO2017004735A2 (en) Molecules Having Pesticidal Utility and Related Intermediates, Compositions, and Procedures
UY34615A (en) NEW USEFUL COMPOUNDS FOR THE TREATMENT OF DEGENERATIVE AND INFLAMMATORY DISEASES.
UY35276A (en) New compounds that inhibit the activity of Lp-PLA2
CL2017001615A1 (en) Pyrazolpyridineamines as inhibitors of mknk1 and mknk2.